-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Plixorafenib in Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Plixorafenib in Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Plixorafenib in Glioma Drug Details: FORE-8394 (PLX-8394) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Cabometyx in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabometyx in Neuroendocrine Tumors report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabometyx in Neuroendocrine Tumors Drug Details: Cabozantinib s-malate (Cabometyx, Aptimetyx) is a...
-
Sector Analysis
United Kingdom (UK) Womenswear Market Size and Trend Analysis by Category, Segments, Region, Key Brands, and Forecast to 2028
UK Womenswear Market Overview The UK womenswear market size was estimated to be £24.8 billion in 2023. The market will witness steady growth at a CAGR of more than 1% during 2023-2028 due to long-term economic improvement. United Kingdom (UK) Womenswear Market Outlook 2023-2028 (£ Billion) Buy the Full Report for More Insights into the UK Womenswear Market, Download a Free Report Sample The UK womenswear market research report offers comprehensive insightsinto the womenswear market in the UK along with the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VRDN-002 in Graves’ Ophthalmopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VRDN-002 in Graves' Ophthalmopathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VRDN-002 in Graves' Ophthalmopathy Drug Details: VRDN-002 is under development for the...
-
Sector Analysis
Edge Computing Market Size, Trends and Analysis by IT Infrastructure, Vertical, Employee Size Band, Region and Segment Forecast to 2027
Accessing the in-depth insights from the ‘Edge Computing’ report can help: Understand the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and Identify competitors' capabilities to stay ahead in the market. Identify segments and know the stakeholders across different stages of the value Anticipate changes in demand and adjust the business development strategies Identify potential regions and countries for growth How is our ‘Edge Computing’ report different from other reports...
-
Sector Analysis
Electrophysiology Ablation Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Electrophysiology Ablation Catheters Market Report Overview The Electrophysiology Ablation Catheters market size was valued at $2.76 billion in 2023 and will grow at a CAGR of more than 4% during the forecast period. One of the key factors driving the Electrophysiology Ablation Catheters market growth is the growing incidence of arrhythmia and heart failure. An Electrophysiology Ablation Catheter is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence....
-
Product Insights
Clot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Case Studies
Magic Spoon – Success Case Study
"Success Case Study: Magic Spoon" is part of GlobalData's Success & Failure case study series. Magic Spoon offers a health-focused range of cereals and cereal bars with flavors intended to invoke nostalgia. It started as a direct-to-consumer model and moved to retail in 2022. The use of alternative ingredients such as monk fruit and allulose allow the cereal to be keto-friendly, grain-free, high in protein, and low in sugar. As of 2023, the brand has successfully received over $100 million...
-
Thematic Analysis
Carbon Offsets – Thematic Intelligence
Reasons to buy the ‘Carbon Offsets’ thematic intelligence report: Get an overview of carbon offsets, which is a major topic within the ESG theme. Obtain a comprehensive introduction to carbon offsets and how they are used to offset greenhouse gas emissions. Acts as a guide to corporate offset strategies and advice on how companies should approach carbon offsets. How is our ‘Carbon Offsets’ report unique from other reports in the market? Get a market overview, types of offsets, and who...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMG-0101 in Chronic Low Back Pain (CLBP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMG-0101 in Chronic Low Back Pain (CLBP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMG-0101 in Chronic Low Back Pain (CLBP) Drug Details:...